Pediatrics International · 1998 · 24 citations · 17 references
MedicineCardiologyPediatricsClinical ImmunologyPediatric CardiologyPediatric ImmunologyAcute Coronary SyndromesCardiac Risk AssessmentCardiovascular DiseaseCoronary Artery DiseasePediatric VasculitisAcute Coronary Syndrome DetectionCase-control Study DesignCoronary Artery AneurysmCoronary Artery Disease DetectionCoronary Lesion AssessmentImmune Globulin TherapyLogistic RegressionSerum Immunoglobulin Function
BACKGROUND: To determine the usefulness of the IgG z-score (age and sex-standardized serum IgG level) before intravenous gamma globulin therapy (IVGG) in predicting the occurrence or severity of coronary complications in Kawasaki disease (KD). METHODS: A case-control study of clinical and laboratory findings with 88 children in the early stage of acute KD who received IVGG (100 or 200 mg/kg for 2-5 days) therapy. Of these, 20 cases had persistent coronary arterial lesions (small aneurysm, moderate aneurysm or large aneurysm persisting more than 1 month). The controls comprised 68 children with no coronary aneurysms or transient small aneurysm only observed within 1 month after the onset of KD. The association between serum levels of immunoglobulin G (IgG). IgM, IgA as well as other coronary risk factors previously reported and the occurrence of the coronary arterial lesions was evaluated using logistic regression analysis. RESULTS: After adjustment for age, gender, total IVGG dose before the 9th illness day and other traditional coronary risk factors, the odds ratio for the persistent coronary aneurysm associated with lower serum IgG z-score (< -0.7485 vs > or = -0.7485), was 30.3 (95% confidence interval, 3.8-243.2). Furthermore, the serum IgG z-score was inversely correlated with the severity of the coronary arterial lesion. CONCLUSIONS: The IgG z-score before IVGG therapy in the early stage of KD provides useful information on the risk factors for persistent coronary aneurysm and is a novel, additional indicator for therapy to prevent the coronary complications in acute KD.
17
A New Infantile Acute Febrile Mucocutaneous Lymph Node Syndrome (MLNS) Prevailing in Japan
Tomisaku Kawasaki, Fumio Kosaki, Sumio Okawa et al. · PEDIATRICS · 1974 · 1.5K citations
Medicine, Pathology, Pediatrics +10
The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin
Jane W. Newburger, Masato Takahashi, Jane C. Burns et al. · New England Journal of Medicine · 1986 · 1.4K citations